학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 317건 | 목록
1~20
Academic Journal
Jernström, S; Hongisto, V; Leivonen, S-K; Due, EU; Tadele, DS; Edgren, H; Kallioniemi, O; Perälä, M; Mælandsmo, GM; Sahlberg, KK
BREAST CANCER-TARGETS AND THERAPY. 9:185-198
Academic Journal
Valsalakumari R; Pandya AD; Prasmickaite L; Kvalvaag A; Myrann AG; Åslund AKO; Kjos MS; Fontecha-Cuenca C; Haroon HB; Ribeiro ARS; Horejs-Hoeck J; Moghimi SM; Mørch Ý; Skotland T; Sandvig K; Mælandsmo GM; Iversen TG
International Journal of Nanomedicine, Vol 19, Pp 3009-3029 (2024)
Academic Journal
Prasmickaite, L; Berge, G; Bettum, IJ; Aamdal, S; Hansson, J; Bastholt, L; Oijordsbakken, M; Boye, K; Maelandsmo, GM
CANCER IMMUNOLOGY IMMUNOTHERAPY. 64(6):769-776
Academic Journal
Trnkova L; Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, Bratislava, Slovakia. Electronic address: lenka.trnkova@savba.sk.; Burikova M; Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, Bratislava, Slovakia. Electronic address: monika.burikova@savba.sk.; Soltysova A; Department of Molecular Biology, Faculty of Natural Sciences, Comenius University in Bratislava, Bratislava, Slovakia; Department of Human Genetics, Institute for Clinical and Translational Research, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava, Slovakia. Electronic address: andrea.soltysova@uniba.sk.; Ficek A; Department of Molecular Biology, Faculty of Natural Sciences, Comenius University in Bratislava, Bratislava, Slovakia. Electronic address: andrej.ficek@uniba.sk.; Plava J; Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, Bratislava, Slovakia. Electronic address: jana.plava@savba.sk.; Cumova A; Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, Bratislava, Slovakia. Electronic address: andrea.cumova@savba.sk.; Rojikova L; Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, Bratislava, Slovakia. Electronic address: lucia.rojikova@savba.sk.; Jakic K; Department of Nanobiology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, Bratislava, Slovakia. Electronic address: kristina.kopecka@savba.sk.; Sedlackova E; Department of Nanobiology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, Bratislava, Slovakia. Electronic address: eva.sedlackova@savba.sk.; Tichy B; Genomics Core Facility, Central European Institute of Technology, Masaryk University, Brno, Czechia. Electronic address: boris.tichy@ceitec.muni.cz.; Bystry V; Bioinformatics Core Facility, Central European Institute of Technology, Masaryk University, Brno, Czechia. Electronic address: vojtech.bystry@ceitec.muni.cz.; Busato F; Laboratory for Epigenetics & Environment, Centre National de Recherche en Génomique Humaine, CEA-Institut de Biologie François Jacob, Université Paris-Saclay, Evry, France. Electronic address: busato@cnrgh.fr.; Shen Y; Laboratory for Bioinformatics, Foundation Jean Dausset - Human Polymorphism Study Center (CEPH), Paris, France. Electronic address: yimin.shen@fjd-ceph.org.; Matuskova M; Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, Bratislava, Slovakia. Electronic address: miroslava.matuskova@savba.sk.; Kucerova L; Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, Bratislava, Slovakia; Translational Research Unit of the 2nd Oncology Clinic, Faculty of Medicine, Comenius University, and National Cancer Institute, Bratislava, Slovakia. Electronic address: lucia.kucerova@fmed.uniba.sk.; Øy GF; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. Electronic address: geirfro@ous-hf.no.; Mælandsmo GM; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; Department of Medical Biology, Faculty of Health Sciences, The Arctic University of Norway-University of Tromsø, Tromsø, Norway. Electronic address: g.m.malandsmo@ous-research.no.; Fleischer T; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. Electronic address: thofle@ous-hf.no.; Tost J; Laboratory for Epigenetics & Environment, Centre National de Recherche en Génomique Humaine, CEA-Institut de Biologie François Jacob, Université Paris-Saclay, Evry, France. Electronic address: tost@cnrgh.fr.; Miklikova S; Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, Bratislava, Slovakia. Electronic address: svetlana.miklikova@savba.sk.; Cihova M; Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, Bratislava, Slovakia. Electronic address: marina.cihova@ru.unb.sk.; Buocikova V; Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, Bratislava, Slovakia. Electronic address: verona.buocikova@savba.sk.; Smolkova B; Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, Bratislava, Slovakia. Electronic address: bozena.smolkova@savba.sk.
Publisher: Churchill Livingstone Country of Publication: Scotland NLM ID: 9815369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2084 (Electronic) Linking ISSN: 13687646 NLM ISO Abbreviation: Drug Resist Updat Subsets: MEDLINE
Academic Journal
Breast Cancer: Targets and Therapy, Vol 14, Pp 25-39 (2022)
Academic Journal
Dahle MA; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Førde JL; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Egeland EV; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Creason AL; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.; Watson C; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.; Garred Ø; Department of Pathology, Oslo University Hospital, Oslo, Norway.; Prasmickaite L; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Mælandsmo GM; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Medical Biology, Faculty of Health Sciences, University of Tromsø - The Arctic University of Norway, Tromsø, Norway.; Mills GB; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.; Division of Oncological Sciences, Oregon Health & Science University, Portland, Oregon, USA.; Engebraaten O; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Haugen MH; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Academic Journal
Emaldi M; Cancer Department, Biobizkaia Health Research Institute, Barakaldo, Spain.; CIBERER, ISCIII, Madrid, Spain.; Rey-Iborra E; Cancer Department, Biobizkaia Health Research Institute, Barakaldo, Spain.; CIBERER, ISCIII, Madrid, Spain.; Marín Á; Cancer Department, Biobizkaia Health Research Institute, Barakaldo, Spain.; Mosteiro L; Cancer Department, Biobizkaia Health Research Institute, Barakaldo, Spain.; CIBERER, ISCIII, Madrid, Spain.; Department of Pathology, Cruces University Hospital, Barakaldo, Spain.; Lecumberri D; Cancer Department, Biobizkaia Health Research Institute, Barakaldo, Spain.; Service of Urology, Urduliz Hospital, Urduliz, Spain.; Øyjord T; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; Roncier N; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; Mælandsmo GM; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; Department of Medical Biology, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.; Angulo JC; Service of Urology, Getafe University Hospital, Getafe, Madrid, Spain.; Clinical Department, Faculty of Biomedical Sciences, European University of Madrid, Madrid, Spain.; Errarte P; Department of Nursing, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, Leioa, Spain.; Larrinaga G; Cancer Department, Biobizkaia Health Research Institute, Barakaldo, Spain.; Department of Nursing, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, Leioa, Spain.; Pulido R; Cancer Department, Biobizkaia Health Research Institute, Barakaldo, Spain.; CIBERER, ISCIII, Madrid, Spain.; Ikerbasque, Basque Foundation for Science, Bilbao, Spain.; López JI; Cancer Department, Biobizkaia Health Research Institute, Barakaldo, Spain.; Nunes-Xavier CE; Cancer Department, Biobizkaia Health Research Institute, Barakaldo, Spain.; CIBERER, ISCIII, Madrid, Spain.; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Academic Journal
Pandya AD; Jäger E; Bagheri Fam S; Höcherl A; Jäger A; Sincari V; Nyström B; Štěpánek P; Skotland T; Sandvig K; Hrubý M; Mælandsmo GM
International Journal of Nanomedicine, Vol 14, Pp 6269-6285 (2019)
Academic Journal
MH Haugen; OC Lindgjærde; M Krohn; W Zhao; EM Lindholm; L Silwal-Pandit; E Borgen; Ø Garred; A Fangberget; MM Holmen; E Schlichting; H Skjerven; S Lundgren; E Wist; B Naume; GM Mælandsmo; Y Lu; A-L Børresen-Dale; GB Mills; O Engebråten
Cancer Research. 77:P6-13
Chemoresistant tumor cell secretome potentiates immune suppression in triple negative breast cancer.
Academic Journal
Skourti E; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. eleni.skourti@studmed.uio.no.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. eleni.skourti@studmed.uio.no.; Seip K; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Mensali N; Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Jabeen S; Department of Clinical Molecular Biology (EPIGEN), Akershus University Hospital, Lørenskog, Norway.; Juell S; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Øynebråten I; Tumor Immunology Lab, Department of Pathology, Rikshospitalet, Oslo University Hospital, Oslo, Norway.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.; Pettersen S; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Engebraaten O; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Corthay A; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Tumor Immunology Lab, Department of Pathology, Rikshospitalet, Oslo University Hospital, Oslo, Norway.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.; Inderberg EM; Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Dolznig H; Institute of Medical Genetics, Medical University of Vienna, Vienna, Austria.; Mælandsmo GM; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Medical Biology, Faculty of Health Sciences, University of Tromsø/The Arctic University of Norway, Tromsø, Norway.; Egeland EV; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Prasmickaite L; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. lina.prasmickaite@ous-research.no.
Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE
Academic Journal
Normann LS; Department of Research and Innovation, Vestre Viken Hospital Trust, Drammen, Norway.; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Medical Genetics, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway.; Haugen MH; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Hongisto V; Division of Toxicology, Misvik Biology, Turku, Finland.; Aure MR; Department of Medical Genetics, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway.; Leivonen SK; Applied Tumor Genomics Research Program, Medical Faculty, University of Helsinki, Helsinki, Finland.; Kristensen VN; Department of Medical Genetics, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway.; Tahiri A; Department of Research and Innovation, Vestre Viken Hospital Trust, Drammen, Norway.; Engebraaten O; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Sahlberg KK; Department of Research and Innovation, Vestre Viken Hospital Trust, Drammen, Norway.; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Mælandsmo GM; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute for Medical Biology, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø, Norway.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Academic Journal
Thulin MH; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research at the Sahlgrenska Academy, University of Gothenburg, Vita Stråket 11, 403 45, Gothenburg, Sweden.; Ramberg H; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Nydalen, P.O. Box 4950, 0424, Oslo, Norway.; Nielsen HK; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Nydalen, P.O. Box 4950, 0424, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Grytli HH; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Nydalen, P.O. Box 4950, 0424, Oslo, Norway.; Sivanesan S; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Nydalen, P.O. Box 4950, 0424, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Urology, Oslo University Hospital, Oslo, Norway.; Pandya AD; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Nydalen, P.O. Box 4950, 0424, Oslo, Norway.; Seip K; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Nydalen, P.O. Box 4950, 0424, Oslo, Norway.; Andressen KW; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Pharmacology, University of Oslo, Kirkeveien 166, 0450, Oslo, Norway.; Linder A; Sahlgrenska Center for Cancer Research, Department of Obstetrics and Gynecology, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, 413 90, Gothenburg, Sweden.; Øijordsbakken M; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.; Poutanen M; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research at the Sahlgrenska Academy, University of Gothenburg, Vita Stråket 11, 403 45, Gothenburg, Sweden.; Katz B; Department of Pathology, Oslo University Hospital, Oslo, Norway.; Halvorsen B; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.; Mælandsmo GM; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Nydalen, P.O. Box 4950, 0424, Oslo, Norway.; Department of Medical Biology, The Artic University of Norway, Tromsø, Norway.; Taskén KA; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Nydalen, P.O. Box 4950, 0424, Oslo, Norway. k.a.tasken@medisin.uio.no.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. k.a.tasken@medisin.uio.no.
Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE
Academic Journal
Valsalakumari R; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, 0379 Oslo, Norway.; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, 0379 Oslo, Norway.; Feith M; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, 0379 Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0379 Oslo, Norway.; Pettersen S; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, 0379 Oslo, Norway.; Åslund AKO; Department of Biotechnology and Nanomedicine, SINTEF AS, 7034 Trondheim, Norway.; Mørch Ý; Department of Biotechnology and Nanomedicine, SINTEF AS, 7034 Trondheim, Norway.; NaDeNo Nanoscience AS, 7051 Trondheim, Norway.; Skotland T; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, 0379 Oslo, Norway.; Centre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, 0379 Oslo, Norway.; Sandvig K; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, 0379 Oslo, Norway.; Centre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, 0379 Oslo, Norway.; Department of Biosciences, University of Oslo, 0316 Oslo, Norway.; Mælandsmo GM; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, 0379 Oslo, Norway.; Department of Medical Biology, University of Tromsø, 9019 Tromsø, Norway.; Iversen TG; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, 0379 Oslo, Norway.; Centre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, 0379 Oslo, Norway.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101534003 Publication Model: Electronic Cited Medium: Print ISSN: 1999-4923 (Print) Linking ISSN: 19994923 NLM ISO Abbreviation: Pharmaceutics Subsets: PubMed not MEDLINE
Academic Journal
Knutsen E; Department of Medical Biology, Faculty of Health Sciences, UiT the Arctic University of Norway, Tromsø, Norway.; Centre for Clinical Research and Education, University Hospital of North Norway, Tromsø, Norway.; Das Sajib S; Department of Medical Biology, Faculty of Health Sciences, UiT the Arctic University of Norway, Tromsø, Norway.; Fiskaa T; Department of Medical Biology, Faculty of Health Sciences, UiT the Arctic University of Norway, Tromsø, Norway.; Lorens J; Department of Biomedicine, University of Bergen, Bergen, Norway.; Gudjonsson T; Department of Anatomy, Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.; Department of Hematology, Landspitali, University Hospital, Reykjavik, Iceland.; Mælandsmo GM; Department of Medical Biology, Faculty of Health Sciences, UiT the Arctic University of Norway, Tromsø, Norway.; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Johansen SD; Department of Medical Biology, Faculty of Health Sciences, UiT the Arctic University of Norway, Tromsø, Norway.; Genomics Division, Faculty of Bioscience and Aquaculture, Nord University, Bodø, Norway.; Seternes OM; Department of Pharmacy, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.; Perander M; Department of Medical Biology, Faculty of Health Sciences, UiT the Arctic University of Norway, Tromsø, Norway.; Centre for Clinical Research and Education, University Hospital of North Norway, Tromsø, Norway.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Academic Journal
Haugen MH; Department of Tumor Biology, Oslo University Hospital Oslo, Norway.; von der Lippe Gythfeldt H; Department of Tumor Biology, Oslo University Hospital Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Norway.; Department of Oncology, Oslo University Hospital, Norway.; Insitute for Clinical Medicine, University of Oslo, Norway.; Egeland EV; Department of Tumor Biology, Oslo University Hospital Oslo, Norway.; Svartdal Normann L; Department of Tumor Biology, Oslo University Hospital Oslo, Norway.; Department of Research and Innovation, Vestre Viken Hospital Trust, Drammen, Norway.; Pandya AD; Department of Tumor Biology, Oslo University Hospital Oslo, Norway.; Vedin LL; Division of Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.; Juell S; Department of Tumor Biology, Oslo University Hospital Oslo, Norway.; Tenstad E; Department of Tumor Biology, Oslo University Hospital Oslo, Norway.; Øy GF; Department of Tumor Biology, Oslo University Hospital Oslo, Norway.; Kristian A; Department of Tumor Biology, Oslo University Hospital Oslo, Norway.; Marangoni E; Translational Research Department, Institut Curie, PSL Research University, Paris, France.; Sørlie T; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Norway.; Insitute for Clinical Medicine, University of Oslo, Norway.; Steffensen K; Division of Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.; Maelandsmo GM; Department of Tumor Biology, Oslo University Hospital Oslo, Norway.; Department of Medical Biology, Faculty of Health Sciences, The Arctic University of Norway-University of Tromsø, Norway.; Engebraaten O; Department of Tumor Biology, Oslo University Hospital Oslo, Norway.; Department of Oncology, Oslo University Hospital, Norway.; Insitute for Clinical Medicine, University of Oslo, Norway.
Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Academic Journal
Hidalgo M; Amant F; Biankin AV; Budinská E; Byrne AT; Caldas C; Clarke RB; de Jong S; Jonkers J; Mælandsmo GM; Roman Roman S; Seoane J; TRUSOLINO, Livio; Villanueva A.
Cancer Discovery
Hidalgo, M, Amant, F, Biankin, A V, Budinská, E, Byrne, A T, Caldas, C, Clarke, R B, de Jong, S, Jonkers, J, Mælandsmo, G M, Roman-Roman, S, Seoane, J, Trusolino, L & Villanueva, A 2014, 'Patient Derived Xenograft Models: An Emerging Platform For Translational Cancer Research', Cancer discovery, vol. 4, no. 9, pp. 998-1013. https://doi.org/10.1158/2159-8290.CD-14-0001
Hidalgo, M, Amant, F, Biankin, A V, Budinská, E, Byrne, A T, Caldas, C, Clarke, R B, de Jong, S, Jonkers, J, Mælandsmo, G M, Roman-Roman, S, Seoane, J, Trusolino, L & Villanueva, A 2014, 'Patient Derived Xenograft Models: An Emerging Platform For Translational Cancer Research', Cancer discovery, vol. 4, no. 9, pp. 998-1013. https://doi.org/10.1158/2159-8290.CD-14-0001
Academic Journal
Ghannoum S; Institute of Basic Medical Sciences, Department of Molecular Medicine, University of Oslo, Oslo, Norway.; Fantini D; Department of Urology, Northwestern University, Chicago, Illinois, United States of America.; Zahoor M; Institute of Basic Medical Sciences, Department of Molecular Medicine, University of Oslo, Oslo, Norway.; Reiterer V; Institute of Pathophysiology, Medical University of Innsbruck, Innsbruck, Austria.; Phuyal S; Institute of Basic Medical Sciences, Department of Molecular Medicine, University of Oslo, Oslo, Norway.; Leoncio Netto W; Oslo Centre for Biostatistics and Epidemiology, Faculty of Medicine, University of Oslo, Oslo, Norway.; Sørensen Ø; Center for Lifespan Changes in Brain and Cognition, Department of Psychology, University of Oslo, Oslo, Norway.; Iyer A; Department of Computational Biology, University of Lausanne (UNIL), Lausanne, Switzerland.; Sengupta D; Department of Computational Biology, Indraprastha Institute of Information Technology, New Delhi, India.; Centre for Artificial Intelligence, Indraprastha Institute of Information Technology, Delhi, India.; Prasmickaite L; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; Mælandsmo GM; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; Department of Medical Biology, UiT-The Arctic University of Norway, Tromsø, Norway.; Köhn-Luque A; Oslo Centre for Biostatistics and Epidemiology, Faculty of Medicine, University of Oslo, Oslo, Norway.; Farhan H; Institute of Basic Medical Sciences, Department of Molecular Medicine, University of Oslo, Oslo, Norway.; Institute of Pathophysiology, Medical University of Innsbruck, Innsbruck, Austria.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238922 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7358 (Electronic) Linking ISSN: 1553734X NLM ISO Abbreviation: PLoS Comput Biol Subsets: MEDLINE
Academic Journal
Cedervall, J; Jamil, S; Prasmickaite, L; Cheng, Y; Eskandarpour, M; Hansson, J; Maelandsmo, GM; Ringborg, U; Gulyas, M; Zhen, HS
CANCER RESEARCH. 69(9):3746-3754
Academic Journal
Pettersen S; Department of Tumor Biology, Radium Hospital, Oslo University Hospital, Oslo, Norway.; Øy GF; Department of Tumor Biology, Radium Hospital, Oslo University Hospital, Oslo, Norway.; Egeland EV; Department of Tumor Biology, Radium Hospital, Oslo University Hospital, Oslo, Norway.; Juell S; Department of Tumor Biology, Radium Hospital, Oslo University Hospital, Oslo, Norway.; Engebråten O; Department of Tumor Biology, Radium Hospital, Oslo University Hospital, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Insitute for Clinical Medicine, University of Oslo, Oslo, Norway.; Mælandsmo GM; Department of Tumor Biology, Radium Hospital, Oslo University Hospital, Oslo, Norway.; Department of Medical Biology, Faculty of Health Sciences, University of Tromsø/the Arctic University of Norway, Tromsø, Norway.; Prasmickaite L; Department of Tumor Biology, Radium Hospital, Oslo University Hospital, Oslo, Norway.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Academic Journal
Egeland EV; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. e.v.egeland@ous-research.no.; Seip K; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; Skourti E; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; Insitute for Clinical Medicine, University of Oslo, Oslo, Norway.; Øy GF; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; Pettersen SJ; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; Pandya AD; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; Dahle MA; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; Insitute for Clinical Medicine, University of Oslo, Oslo, Norway.; Haugen MH; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; Department of Research and Innovation, Vestre Viken Hospital Trust, Drammen, Norway.; Kristian A; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; Nakken S; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Centre for Bioinformatics, Department of Informatics, University of Oslo, Oslo, Norway.; Engebraaten O; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; Insitute for Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Mælandsmo GM; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; Department of Medical Biology, Faculty of Health Sciences, The Arctic University of Norway-University of Tromsø, Tromsø, Norway.; Prasmickaite L; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Mælandsmo GM
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어